Safety Alerts & Recalls
The Food and Drug Administration (FDA) is warning consumers not to buy or use "Feng Shi Ling," a product marketed as an herbal drug for pain due to rheumatoid arthritis and osteoporosis.
REFA Enterprises, LLC announced a voluntary recall of Forever Beautiful Bee Pollen and Forever Beautiful Infinity products after they were found to contain undeclared ingredients. Both products are marketed as dietary supplements for weight loss.
Solgar announced a voluntary recall of ABC Dophilus Powder due to the discovery of Rhizopus oryzae, which may cause Mucormycosis.
The Food and Drug Administration (FDA) has expressed concerns about the therapeutic equivalence of 2 generic versions of Concerta (methylphenidate HCl extended-release; Janssen) tablets indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
The Food and Drug Administration (FDA) is warning consumers not to buy or use Mayhem, a dietary supplement marketed to increase appetite and muscle growth after it was found to contain an undeclared corticosteroid and antihistamine.
The Food and Drug Administration (FDA) is warning consumers to not buy or use V26 Slimming Coffee, a product sold for weight loss.
The FDA is alerting healthcare professionals and emergency responders that certain lots of AtroPen (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors manufactured by Meridian Medical Technologies can be used for up to one year beyond the labeled expiration date.
Contract Packaging Resources announced a voluntary recall of 11,640 boxes of Assured brand Naproxen Sodium Tablets due to some cartons containing bottles of Ibuprofen.
Hospira announced a voluntary recall of 1% Lidocaine HCl for Injection after a confirmed report of human hair in a single unit.
Hospira announced a voluntary recall of various lots of several intravenous (IV) solutions in its LifeCare line due to potential for leakage.